ESR1 and neoplasm: CC patients displayed poorer survival compared to non-GRCC patients after accounting for age, stage, tumor grade, ER/PR/HER2 status, surgery and radiation (HR: 1.33; 95% CI: 1.00–1.76; p = 0.047).